Skyrizi (risankizumab) is a biologic medication that works by targeting a protein called IL-23, which plays a role in causing inflammation. By blocking this protein, it helps reduce the immune response that leads to psoriasis symptoms.
However, when it comes to guttate psoriasis specifically, biologics like Skyrizi are not Show Full Answer
Skyrizi (risankizumab) is a biologic medication that works by targeting a protein called IL-23, which plays a role in causing inflammation. By blocking this protein, it helps reduce the immune response that leads to psoriasis symptoms.
However, when it comes to guttate psoriasis specifically, biologics like Skyrizi are not typically the first line of treatment. Most guidelines recommend starting with topical creams or light therapy first. Biologics are generally only considered for guttate psoriasis in more severe cases that haven't responded to other treatments. The evidence for using biologics in guttate psoriasis is still quite limited — mostly small studies and individual case reports.
It's worth noting that Skyrizi does carry some potential side effects, including:
- Serious allergic reactions (swelling, hives, breathing difficulties)
- Increased risk of infections
- Lightheadedness or fainting
A conversation with a dermatologist would be the best way to explore whether Skyrizi could be a suitable option based on the severity of symptoms and treatment history.
July 7
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
